Abstract
Amiodarone, a widely utilized antiarrhythmic drug, poses a significant risk of amiodarone-induced lung toxicity (ALT) in up to 10% of patients and can be fatal. This report presents the diagnostic challenges associated with ALT, given its non-specific clinical and radiological presentation. Clinicians should maintain a high index of suspicion for potential ALT, especially in patients with progressive respiratory failure despite optimization of other potential causes such as CHF. The mainstay of treatment is discontinuing amiodarone and initiating steroids. However, outcomes can remain unpredictable, emphasizing the need for heightened awareness and regular monitoring of patients on amiodarone therapy.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Recommended Citation
Takla A, Eid F, Ukrani H, Mohamed M, Lee E. Amiodarone-Induced Lung Toxicity: An underrecognized and fatal presentation. Advances in Clinical Medical Research and Healthcare Delivery. 2024; 4(2). doi: 10.53785/2769-2779.1215.
Amiodarone.jpg
1.png (729 kB)
2.png (533 kB)
Title page.docx (13 kB)
Separate artwork1.png (649 kB)
Separate artwork2.png (483 kB)
Captions.docx (13 kB)
TNQ response.docx (13 kB)
TNQ response.docx (13 kB)